Moderna Inc reported 5.6B in Cash and Equivalent for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US $ 266.96M 37.53M
Acorda Therapeutics ACOR:US $ 45.71M 71.06M
Agios Pharmaceuticals AGIO:US $ 969.12M 918.9M
Alexion Pharmaceuticals ALXN:US $ 3429.6M 465.1M
Alnylam Pharmaceuticals ALNY:US $ 745.77M 366.22M
Amgen AMGN:US $ 6630M 518M
Arrowhead Research ARWR:US $ 325.98M 46.4M
Biogen BIIB:US $ 1742M 524.5M
Biomarin Pharmaceutical BMRN:US $ 641.53M 25.78M
Bluebird Bio BLUE:US $ 353.47M 86.25M
Esperion Therapeutics ESPR:US $ 219.19M 1.25M
Gilead Sciences GILD:US $ 7361M 3296M
GlaxoSmithKline GSK:LN 3503M 1254M
Gw Pharmaceuticals GWPH:US $ 458.1M 28.65M
Intercept Pharmaceuticals ICPT:US $ 145.62M 52.67M
IONIS PHARMACEUT IONS:US $ 565.12M 150.96M
Mirati Therapeutics MRTX:US $ 258.99M 35.9M
Puma Biotechnology PBYI:US $ 89.85M 5.8M
Regeneron Pharmaceuticals REGN:US $ 2072.2M 634.3M
Sangamo Biosciences SGMO:US $ 169.88M 46.9M
Sarepta Therapeutics SRPT:US $ 1697.28M 215.44M
Seattle Genetics SGEN:US $ 413.43M 39.72M
Ultragenyx Pharmaceutical RARE:US $ 290.88M 92.92M
United Therapeutics UTHR:US $ 942.2M 109.9M
Vertex Pharmaceuticals VRTX:US $ 6063.68M 240.65M
YTE INCY:US $ 1797.58M 127.61M